Trials / Completed
CompletedNCT04375150
Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC
Study of Advanced Renal Cell Carcinoma Treatment Patterns and Unmet Needs Using Real World Claims and Electronic Medical Record Data.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 355 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to assess treatment patterns and outcomes in advanced RCC patients in real world clinical practices across various real world databases. Four databases will be evaluated
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tyrosine kinase inhibitor (TKI) | TKIs |
| DRUG | Immuno-oncology (IO) | IOs |
Timeline
- Start date
- 2019-12-02
- Primary completion
- 2022-10-28
- Completion
- 2022-10-28
- First posted
- 2020-05-05
- Last updated
- 2024-09-19
- Results posted
- 2024-09-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04375150. Inclusion in this directory is not an endorsement.